Search Results - "Rad, S.M. Ali Hosseini"
-
1
Tracking COVID-19 with wastewater to understand asymptomatic transmission
Published in International journal of infectious diseases (01-07-2021)“…•This study provided the first dataset related to SARS-CoV-2 RNA in wastewater in Bangkok.•A rise in SARS-CoV-2 RNA level in wastewater preceded an increase in…”
Get full text
Journal Article -
2
Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection
Published in Biomedicine & pharmacotherapy (01-12-2023)“…Given the rise of multidrug-resistant (MDR) Pseudomonas aeruginosa infections, alternative treatments are needed. Anti-pseudomonal phage therapy shows promise,…”
Get full text
Journal Article -
3
Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections
Published in iScience (21-07-2023)“…Developing an effective therapy to overcome carbapenemase-positive Klebsiella pneumoniae (CPKp) is an important therapeutic challenge that must be addressed…”
Get full text
Journal Article -
4
Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission
Published in iScience (15-03-2024)“…This study investigated the potential of using SARS-CoV-2 viral concentrations in dust as an additional surveillance tool for early detection and monitoring of…”
Get full text
Journal Article -
5
Multiple traces of monkeypox detected in non-sewered wastewater with sparse sampling from a densely populated metropolitan area in Asia
Published in The Science of the total environment (01-02-2023)“…The monkeypox virus is excreted in the feces of infected individuals. Therefore, there is an interest in using viral load detection in wastewater for sentinel…”
Get full text
Journal Article -
6
Regulation of human Mcl-1 by a divergently-expressed antisense transcript
Published in Gene (15-12-2020)“…•Mcl-1 expression is negatively regulated by an antisense transcript (Mcl1-AS1)•Mcl1-AS1 is predicted to bind to Mcl-1 mRNA.•The first exon and intron act as a…”
Get full text
Journal Article -
7
Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1
Published in The Lancet infectious diseases (01-06-2024)“…In nasopharyngeal samples, significant differences in SARS-CoV-2 RNA concentration were observed between JN.1 and BA.2.86 (p=0·0046), and HV.1 (p=0·0014) on…”
Get full text
Journal Article -
8
Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south
Published in The Lancet infectious diseases (01-10-2024)“…There was a co-occurrence of MPXV-positive condoms with some of the sexually transmitted diseases (Neisseria gonorrhoeae, herpes simplex virus type 1 [HSV-1],…”
Get full text
Journal Article -
9
Optimisation of Tet-On inducible systems for Sleeping Beauty-based chimeric antigen receptor (CAR) applications
Published in Scientific reports (04-08-2020)“…Regulated expression of genetic elements that either encode polypeptides or various types of functional RNA is a fundamental goal for gene therapy. Inducible…”
Get full text
Journal Article -
10
Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study
Published in JMIR bioinformatics and biotechnology (19-07-2022)“…Background Since the first appearance of SARS-CoV-2 in China in December 2019, the world witnessed the emergence of the SARS-CoV-2 outbreak. Due to the high…”
Get full text
Journal Article -
11
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
Published in EClinicalMedicine (01-04-2024)“…Repurposed drugs with host-directed antiviral and immunomodulatory properties have shown promise in the treatment of COVID-19, but few trials have studied…”
Get full text
Journal Article -
12
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trialResearch in context
Published in EClinicalMedicine (01-04-2024)“…Background: Repurposed drugs with host-directed antiviral and immunomodulatory properties have shown promise in the treatment of COVID-19, but few trials have…”
Get full text
Journal Article -
13
Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiellapneumoniae infections
Published in iScience (21-07-2023)“…Developing an effective therapy to overcome carbapenemase-positive Klebsiella pneumoniae (CPKp) is an important therapeutic challenge that must be addressed…”
Get full text
Journal Article